menu
    • menu

    Company profile for Mereo BioPharma Group

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mereo is a UK-based specialty biopharma company established to address the R&D and financial challenges faced by an increasing number of large pharma and biotech companies. Mereo’s business model brings clear benefits to these companies, to investors, and to patients. Large pharmaceutical companies’ pipelines have a significant number of promising new product candidates, but increasing P&L pressures and competition for R&D...
    Mereo is a UK-based specialty biopharma company established to address the R&D and financial challenges faced by an increasing number of large pharma and biotech companies. Mereo’s business model brings clear benefits to these companies, to investors, and to patients. Large pharmaceutical companies’ pipelines have a significant number of promising new product candidates, but increasing P&L pressures and competition for R&D resources combined with strategic changes of direction mean that some of these candidates are not advanced.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mereo BioPharma Groupunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    1 Cavendish Place London W1G 0QF
    Telephone
    Telephone
    +44 (0)333 023 7300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mereobiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mereo Biopharma Reveals Setrusumab (UX143) Phase 3 Results
    Mereo Biopharma Reveals Setrusumab (UX143) Phase 3 Results

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210923/0/en/Mereo-BioPharma-Announces-Phase-3-ORBIT-and-COSMIC-Results-for-Setrusumab-UX143-in-Osteogenesis-Imperfecta.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Mereo Biopharma Reveals Q3 2025 Financials And Corporate
    Mereo Biopharma Reveals Q3 2025 Financials And Corporate

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185063/0/en/Mereo-BioPharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Mereo BioPharma Q2 2025 Financial Results & Corporate Highlights
    Mereo BioPharma Q2 2025 Financial Results & Corporate Highlights

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3131598/0/en/Mereo-BioPharma-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share
    Ultragenyx, Mereo Plummet After Rare Diseases Trial Result
    Ultragenyx, Mereo Plummet After Rare Diseases Trial Result

    11 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/09/3112877/20739/en/Ultragenyx-and-Mereo-BioPharma-Announce-UX143-Phase-3-Orbit-Study-for-Osteogenesis-Imperfecta-Progressing-to-Final-Analysis.html

    GLOBENEWSWIRE
    11 Jul 2025
    Share Share
    Mereo BioPharma Reports Q1 2025 Financial Results and Highlights
    Mereo BioPharma Reports Q1 2025 Financial Results and Highlights

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080008/0/en/Mereo-BioPharma-Reports-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    Mereo BioPharma Reports 2024 Financial Results & Highlights
    Mereo BioPharma Reports 2024 Financial Results & Highlights

    26 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/26/3049535/0/en/Mereo-BioPharma-Reports-Full-Year-2024-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    26 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search